Angiogenesis in hypersensitivity pneumonitis

Archives of Physiology and Biochemistry

Volumn 111, Issue 4, 2003, Pages 365-368

  Navarro, Carmen ^a   Ruiz, V ^a   Gaxiola, M ^a   Carrillo, G ^a   Selman, M ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Angiogenesis; Hypersensitivity pneumonitis; Vascular endothelial growth factor

Indexed keywords

RNA; VASCULOTROPIN; VASCULOTROPIN A;

ALLERGIC PNEUMONITIS; ANGIOGENESIS; BRONCHUS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG LAVAGE; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ALVEOLITIS, EXTRINSIC ALLERGIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 14344257372     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1080/13813450312331337612     Document Type: Conference Paper

References (25)

1. Barrowcliff DF, Arblaster PG (1968): Farmer's lung: a study of an early acute fatal case. Thorax 23: 490-500.
2. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D (2001): The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nature Med 7: 569.
3. Beck L, D'Amore P (1997): Vascular development: cellular and molecular regulation. FASEB J 11: 365-373.
4. Beckner ME (1999): Factors promoting tumor angiogenesis. Cancer Invest 17: 594-623.
5. Colville-Nash PR, Willoughby DA (1997): Growth factors in angiogenesis: current interest and therapeutic potential. Mol Med Today 3: 14-23.
6. Hanahan D (1997): Signaling vascular morphogenesis and maintenance. Science 277: 48-50.
7. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K (1997): Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
8. Kawanami O, Basset F, Barrios R, Lacronique JG, Ferrans VJ, Crystal RG (1983): Hypersensitivity pneumonitis in man. Light and electron microscopy studies of 18 lung biopsies. Am J Pathol 110: 275-289.
9. Keane MP, Arenberg DA, Lynch JP 3rd, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SI, Strieter RM (1997): The CXC chemokine, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immnunol 159: 1437-1443.
10. Keane M, Belperio J, Arenberg D, Burdick M, Xu ZJ, Xue YY, Strieter RM (1999): IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163: 5686-5692.
11. Klagsbrun M, Moses MA (1999): Molecular angiogenesis. Chem Biol 6: R217-R224.
12. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995): Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376: 517-519.
13. Llan N, Madri JA (1999): New paradigms of signaling in the vasculature: ephrins and metalloproteases. Curr Opin Biotech 10: 536-540.
14. Maisonpierre PC, Suri Ch, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulus N, Daly TJ, Davis S, Sato TN, Yancopoulos GC (1997): Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
15. Moore BB, Keane MP, Addison CL, Arenberg DA, Strieter RM (1998): CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Investig Med 46: 113-120.
16. Neufelt G., Cohen T, Gengrinovich S, Poltorak Z (1999): Vascular endothelial growth factor (VEGF) and its receptor. FASEB J 13: 9-12.
17. Pardo A, Barrios R, Gaxiola M, Segura L, Carrillo G, Estrada A, Mejía M, Selman M (2000): Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 161: 1698-1704.
18. Pepper MS (1997): Manipulating angiogenesis: from basic science to the bedside. Arterioscler Thromb Vasc Biol 17: 605-619.
19. Reijula K, Sutinen S (1986): Ultrastructure of extrinsic bronchiolo-alveolitis. Pathol Res Pract 181: 418-429.
20. Seal RME, Hapke EJ, Thomas GO, Meek JC, Rayes M (1968): The pathology of the acute and chronic stages of farmer's lung. Thorax 23: 469-489.
21. Selman M (1998): Hypersensitivity pneumonitis. In: Schwarz M, King TE, eds., Interstitial lung disease, Hamilton, ON, Canada, Decker, pp. 393-322.
22. Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA (2001): Disruption of matrix metalloproteinase 2 binding to integrin αvb3 by a organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci 98: 119-124.
23. Stricter R, Belperio J, Keane M (2002): CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest 122: 298S-301S.
24. Takemura T, Hiraga Y, Oomichi M, Oritsu M, Akiyama O, Matsui Y, Ershi Y, Mikami R (1995): Ultrastructural features of alveolitis in sarcoidosis. Am J Respir Crit Care Med 152: 360-366.
25. Watanabe T, Yasuda M, Yamamoto T (1999): Angiogenesis induced by tissue factor in vitro and in vivo. Thrombosis Res 96: 183-189.